Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission

Aims To evaluate a telemonitoring strategy based on automated text messaging and telephone support after heart failure (HF) hospitalization. Methods and results The MESSAGE‐HF study is a prospective multicentre, randomized, nationwide trial enrolling patients from 30 clinics in all regions of Brazil...

Descripción completa

Detalles Bibliográficos
Autores: Rohde, Luis E, Hoffmann Filho, Conrado R, Rover, Marciane M, Rabelo Silva, Eneida Rejane, López Pedraza, Leticia, Passos, Luiz C S, Silvestre, Odilson M, Martins, Silvia M, Figueiredo Neto, José A de, Silveira, Fábio S, Canesin, Manoel F, Simões, Marcus V, Akio Nishijuka, Fábio, Bertoldi, Eduardo G, Danzmann, Luiz C, Mourilhe Rocha, Ricardo, Hettwer Magedanz, Ellen, Esteves, Mauro, Castilho, Fábio M de, Fernandes Silva, Miguel M, F Ritt, Luiz E, Blacher, Mariana, Soares, Rafael M, Cavalcanti, Alexandre B, Ramirez, Felix
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/133263
Acceso en línea:https://hdl.handle.net/20.500.14352/133263
Access Level:acceso abierto
Palabra clave:616-083
Heart failure
Natriuretic peptide
Telemonitoring
Enfermería
3299 Otras Especialidades Médicas
Descripción
Sumario:Aims To evaluate a telemonitoring strategy based on automated text messaging and telephone support after heart failure (HF) hospitalization. Methods and results The MESSAGE‐HF study is a prospective multicentre, randomized, nationwide trial enrolling patients from 30 clinics in all regions of Brazil. HF patients with reduced left ventricular ejection fraction (<40%) and access to mobile phones are eligible after an acute decompensated HF hospitalization. Patients meeting eligibility criteria undergo an initial feasibility text messaging assessment and are randomized to usual care or telemonitoring intervention. All patients receive a HF booklet with basic information and recommendations about self‐care. Patients in the intervention group receive four daily short text messages (educational and feedback) during the first 30 days of the protocol to optimize self‐care; the feedback text messages from patients could trigger diuretic adjustments or a telephone call from the healthcare team. After 30 days, the frequency of text messages can be adjusted. Patients are followed up after 30, 90, and 180 days, with final status ascertained at 365 days by telephone. Our primary endpoint is the change in N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) levels after 180 days. Secondary endpoints include changes in NT‐proBNP after 30 days; health‐related quality of life, HF self‐care, and knowledge scales after 30 and 180 days; and a composite outcome of HF hospitalization and cardiovascular death, adjudicated by a blinded and independent committee. Conclusions The MESSAGE‐HF trial is evaluating an educational and self‐care promotion strategy involving a simple, intensive, and tailored telemonitoring system. If proven effective, it could be applied to a broader population worldwide.

Similares en LA Referencia